Gubra AS (STU:PI3) Risk Assessment


STU:PI3 Gubra AS STU:PI3
60 GF Score
Price €47.60
GF Value €384.83
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Gubra AS Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Gubra AS is: High Risk: Good fundamentals, beware of shrinking business.

Gubra AS  (STU:PI3) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Gubra AS Risk Assessment Related Terms

STU:PI3 vs VRTX, REGN, ALNY: Risk Assessment Comparison

For the Biotechnology subindustry, Gubra AS's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gubra AS Risk Assessment vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gubra AS's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Gubra AS's Risk Assessment falls into.


STU:PI3
60GF Score
Gubra AS STU:PI3
Risk Assessment is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Gubra AS (STU:PI3) Overvalued in 2026?

Based on GuruFocus' analysis, Gubra AS stock appears to be undervalued. The current stock price of €47.60 is trading 87.6% below its estimated GF Value™ of €384.83. GuruFocus considers Gubra AS to be Possible Value Trap.

Key valuation signals for STU:PI3:

  • Risk Assessment:
  • GF Value™: €384.83 vs. price of €47.60 (87.6% below fair value)
  • GF Score™: 60/100 with 3 warning signs

No single metric tells the full story. See the STU:PI3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Gubra AS Business Description

Other Exchanges GUBRA:Denmark
Address Horsholm Kongevej 11B, Horsholm, DNK, 2970
Gubra AS is a specialized preclinical CRO and biotech company focused on peptide-based drug discovery within metabolic and fibrotic diseases. The company has two segments: Pre-clinical contract research (CRO), which derives maximum revenue and Biotech Segment. It derives maximum revenue from Pre-clinical contract research (CRO) segment. Geographically, the company operates in Europe, North America and Other regions.
60GF Score

Get the complete analysis for STU:PI3

Risk Assessment is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€47.60
Price
€384.83
GF Value